Pre-trial Data for Non-Small Cell Lung Cancer Investigational Drug Revealed by ARIAD
Lung cancer News, News
ARIAD Pharmaceuticals recently revealed results of its investigational tyrosine kinase inhibitor (TKI), AP32788, that is designed to target specific mutations in patients with non-small cell lung cancer (NSCLC) but without ... Read more